CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Caladrius Biosciences, Inc.  (NBS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

Caladrius Biosciences Income Statement Quarterly

NBS


INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Total Revenue 7.923 10.177 9.317 8.300 7.489
   Cost of Revenue 8.042 9.245 8.611 7.052 6.228
Gross Profit -0.120 0.931 0.706 1.249 1.261
   Selling, Administration, Marketing 5.949 4.274 4.936 4.706 6.458
   Depriciation & Amortization - - - - -
   Research and Development Expense 3.463 2.574 2.631 4.028 5.876
   Impairment of Intangible Assets, Finite-lived - - - - -
   Other operatinig exp. /-income -0.000 0.000 - -0.000 -
   Unusual Expense /-Income - - - - -
 Total operating costs including COS 17.454 16.093 16.178 15.785 18.563
Operating income/-loss -9.532 -5.917 -6.861 -7.485 -11.073
Other Deductions / - Income
   Interest expense 0.168 0.186 0.385 0.360 0.927
   Interest income - - - - -
   Net interest expense/-income 0.168 0.186 0.385 0.360 0.927
   Loss/ -Gain on Investment - - - - -
   Foreign Currency Transaction (Gain) Loss - - - - -
   Allowances, Health Care Trust Fund And Other - - - - -
   Unexpected (Gain) Loss - - - - -
   Other loss/ -income 0.044 -0.004 -0.005 -0.007 -0.006
 Total costs & expenses 17.666 16.275 16.558 16.138 19.484
Income /-loss before income taxes -9.744 -6.099 -7.241 -7.838 -11.994
   Income taxes expenses/-benefit 0.050 -0.009 0.047 0.047 0.053
Income after income taxes -9.793 -6.089 -7.288 -7.885 -12.048
   Net income/-loss of other equity -0.000 -0.000 - 0.000 -
Income/-loss from cont. Ops. -9.793 -6.089 -7.288 -7.885 -12.048
   Accounting change - - - - -
   Discontinued operations - - - - -
   Extraordinary items - - - - -
Net Income/-loss -9.793 -6.089 -7.288 -7.885 -12.048
   Noncontrolling interests - - - - -
   Prefered dividends - - - - -
   Other -0.433 -0.131 -0.405 -0.050 -0.067
Income/-loss to shareholder -9.360 -5.958 -6.883 -7.835 -11.981
   EBIT -9.576 -5.912 -6.856 -7.478 -11.068
   EBITD -8.921 -5.262 -6.185 -6.793 -10.330
   EBITDA -8.921 -5.262 -6.185 -6.793 -10.330

Per Share (GAAP Quarterly, in $) (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Basic EPS (excl. extra items) -1.12 -1.01 -1.09 -1.33 -0.21
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -1.12 -1.01 -1.09 -1.33 -0.21
Basic shares outstanding (Mill. of Units) 8.387 5.907 6.323 5.907 57.380
   EPS other shares - - - - -
Diluted Net EPS -1.12 -1.01 -1.09 -1.33 -0.21
Diluted average shares (Mill. of Units) 8.387 5.907 6.323 5.907 57.380
Dividend per share - - - - -


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com